Noosa News
Sun Pharma slashes Tasmanian poppy production following slump in global demand for pain relief
The reduced need for surgical pain relief during the pandemic has forced Tasmanian poppy processor Sun Pharma to cut its growing area for the coming season.
Key points:
- Sun Pharma has slashed the size of its growing area across Tasmania as global demand for painkillers falls
- Twenty growers in the state’s south will be cut and a further 150 will have their contracts reduced
- Worldwide demand for opium-based pain relief dropped to an all-time low last year as elective surgeries were cancelled
The multinational, which contracts growers across the state to produce poppies for its factory at Latrobe, has also made two field officers redundant as part of the cuts.
Worldwide demand for opium-based pain relief dropped to an all-time low last…
Continue Reading
-
Noosa News14 hours agoFormer NRL player Teui ‘TC’ Robati lured woman to pub toilet before alleged rape, jury told
-
Noosa News22 hours agoCattle claimants ‘bitterly disappointed’ after court downplays compensation claim from live export ban
-
General19 hours agoArtificial intelligence could help plan cities, but there are downsides
-
General14 hours agoGetty argues its UK copyright case does not threaten AI